Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
PT Medikaloka Hermina Tbk's Other Stockholders Equity for the quarter that ended in Jun. 2026 was Rp-482,922 Mil.
PT Medikaloka Hermina Tbk's quarterly Other Stockholders Equity
increased
from Dec. 2025 (Rp-497,175 Mil) to Mar. 2026 (Rp-496,894 Mil) and
increased
from Mar. 2026 (Rp-496,894 Mil) to Jun. 2026 (Rp-482,922 Mil).
PT Medikaloka Hermina Tbk's annual Other Stockholders Equity
declined
from Dec. 2023 (Rp-427,405 Mil) to Dec. 2024 (Rp-514,486 Mil) but then
increased
from Dec. 2024 (Rp-514,486 Mil) to Dec. 2025 (Rp-497,175 Mil).
PT Medikaloka Hermina Tbk Other Stockholders Equity Related Terms
PT Medikaloka Hermina Tbk Other Stockholders Equity Historical Data
* Premium members only.
The historical data trend for PT Medikaloka Hermina Tbk's Other Stockholders Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PT Medikaloka Hermina Tbk Other Stockholders Equity Chart
What does a Other Stockholders Equity of Rp-482,922 Mil mean?
PT Medikaloka Hermina Tbk (ISX:HEAL) has a Other Stockholders Equity of Rp-482,922 Mil as of Jun. 2026. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on PT Medikaloka Hermina Tbk and its competitors.
Is PT Medikaloka Hermina Tbk's Other Stockholders Equity too high?
PT Medikaloka Hermina Tbk's current Other Stockholders Equity is Rp-482,922 Mil. Overall, PT Medikaloka Hermina Tbk has a GF Score™ of 68/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does PT Medikaloka Hermina Tbk's Other Stockholders Equity compare to HCA and THC?
PT Medikaloka Hermina Tbk's Other Stockholders Equity of Rp-482,922 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Stockholders Equity for a Healthcare Providers & Services company?
A good Other Stockholders Equity depends on the Healthcare Providers & Services industry context. However, Other Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Stockholders Equity mean?
A high Other Stockholders Equity can signal that a stock is expensive relative to its fundamentals. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on PT Medikaloka Hermina Tbk and its competitors. PT Medikaloka Hermina Tbk's current Other Stockholders Equity is Rp-482,922 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Medikaloka Hermina Tbk stock overvalued right now?
Based on GuruFocus' analysis, PT Medikaloka Hermina Tbk (ISX:HEAL) is currently considered Significantly Undervalued. The stock's GF Value™ is Rp1,558.24, compared to a current price of Rp760.00 — trading 51.2% below its estimated fair value. The current Other Stockholders Equity is Rp-482,922 Mil. PT Medikaloka Hermina Tbk's overall GF Score™ is 68/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Stockholders Equity calculated?
Other Stockholders Equity is calculated from a company's financial statements. For PT Medikaloka Hermina Tbk (ISX:HEAL), the current Other Stockholders Equity is Rp-482,922 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is PT Medikaloka Hermina Tbk (ISX:HEAL) Overvalued in 2026?
Based on GuruFocus' analysis, PT Medikaloka Hermina Tbk stock appears to be undervalued.
The current stock price of Rp760.00 is trading 51.2% below its estimated GF Value™ of Rp1,558.24.
GuruFocus considers PT Medikaloka Hermina Tbk to be Significantly Undervalued.
Key valuation signals for ISX:HEAL:
Other Stockholders Equity: Rp-482,922 Mil
GF Value™: Rp1,558.24 vs. price of Rp760.00 (51.2% below fair value)
No single metric tells the full story. See the ISX:HEAL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
PT Medikaloka Hermina Tbk is a private hospital group. It provides a range of medical services, including maternal and child health services, complex operating procedures, laboratory services, radiology facilities, and fertility treatments as well as general health services, pharmacies, diagnostic and emergency services. The company's geographical segment includes Kalimantan dan Sulawesi, Jawa, and Sumatera. It derives maximum revenue from the Jawa segment.
68GF Score
Get the complete analysis for ISX:HEAL
Other Stockholders Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ISX:HEAL has been successfully added to your 
